New in-demand report "Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules" developed by FirstWord has been recently published by Market Publishers Ltd. The report states that the most recent clinical trials of a new multiple sclerosis therapy were launched in Canada.

London, UK (PRWEB) October 02, 2012

Besides, new therapies are invented. For instance, the most recent clinical trials of a new therapy were launched in late September 2012 in Canada.

New in-demand report "Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules" developed by FirstWord has been recently published by Market Publishers Ltd.

Report Details:

Title: Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules

Published: September, 2012

Price: US$ 7,495.00 http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/therapy-trends-multiple-sclerosis-kol-insight-n-consensus-outlook-modules.html

The report provides a comprehensive guide to trends in multiple sclerosis therapy. It covers historical sales from 2006 through 2011, market majors and drug developers. The study includes valuable data on current and late-stage pipeline drugs, comparative clinical trial results. Sales outlook to 2016, product positioning forecast, market growth expectations as well as future event mapping can also be found in the research.

Report Contents:

More here:
Trends in Multiple Sclerosis Therapy Examined in New Insightful FirstWord Report Published at MarketPublishers.com